| Authors: |
Schoonbeek MC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Gestraud P; INSERM U1331 Computational Oncology, Institut Curie, PSL Research University, Mines Paris Tech, Paris, France., Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Boltjes A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Luik M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Del Nery E; BioPhenics High-Content Screening Laboratory, Department of Translational Research, Curie Institute, Paris, France., Bellini A; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Chua E; INSERM U1331 Computational Oncology, Institut Curie, PSL Research University, Mines Paris Tech, Paris, France., Swaak S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Looze EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pietiäinen VM; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki FI, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Turunen LL; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki FI, Helsinki, Finland., Saarela JS; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki FI, Helsinki, Finland., Schueler J; Charles River Laboratories Germany GmbH, Freiburg, Germany., Indersie E; Xentech, Evry, France., Gürgen D; Experimental Pharmacology and Oncology Berlin-Buch GmbH, Berlin, Germany., Scotlandi K; IRCCS Istituto Ortopedico Rizzoli, Experimental Oncology Laboratory, Bologna, Italy., Eggert A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bouarich-Bourimi R; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Bourdeaut F; Paris Cité University, Paris, France, U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, Curie Institute, Paris, France., Zaidi S; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Surdez D; Balgrist University Hospital, Faculty of Medicine, University of Zurich (UZH), Zurich, Switzerland., Carcaboso ÁM; SJD Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Sant Joan de Déu Barcelona Hospital, Institut de Recerca Sant Joan de Deu (IRSJD), Barcelona, Spain., Geoerger B; Gustave Roussy Cancer Campus, Villejuif, France., Federico A; Hopp Children's Cancer Center (KiTZ), DKFZ and German Cancer Consortium (DKTK), Heidelberg, Germany.; TRON-Translational Oncology at the University Medical Centre of the Johannes Gutenberg University, Mainz, Germany., Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Hopp Children's Cancer Center (KiTZ), DKFZ and German Cancer Consortium (DKTK), Heidelberg, Germany.; Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands., Iddir Y; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Saint-Charles A; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Saberi-Ansari E; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Cavalli F; INSERM U1331 Computational Oncology, Institut Curie, PSL Research University, Mines Paris Tech, Paris, France., Gopisetty A; Hopp Children's Cancer Center (KiTZ), DKFZ and German Cancer Consortium (DKTK), Heidelberg, Germany.; ITCC-P4 gGmbH, Heidelberg, Germany., Rief EM; ITCC-P4 gGmbH, Heidelberg, Germany., Caron HN; Hoffman-La Roche, Basel, Switzerland., Stancato L; ITCC-P4 gGmbH, Heidelberg, Germany.; Indiana Biosciences Research Institute, Indianapolis, IN, USA., Vassal G; Gustave Roussy Cancer Campus, Villejuif, France.; ITCC-P4 gGmbH, Heidelberg, Germany., Pfister S; Hopp Children's Cancer Center (KiTZ), DKFZ and German Cancer Consortium (DKTK), Heidelberg, Germany.; ITCC-P4 gGmbH, Heidelberg, Germany., Koster J; Amsterdam UMC, R2 Platform, Amsterdam, The Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Amsterdam UMC, Amsterdam, The Netherlands., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Schleiermacher G; RTOP (Translational Research in Pediatric Oncology), U1330 INSERM, SIREDO Integrated Pediatric Oncology Center, PSL University, Curie Institute, Paris, France., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.j.molenaar@prinsesmaximacentrum.nl.; Utrecht University, Department of Pharmaceutical Sciences, Utrecht, The Netherlands. j.j.molenaar@prinsesmaximacentrum.nl. |
